Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1277623
Max Phase: Preclinical
Molecular Formula: C26H32N4O6S2
Molecular Weight: 560.70
Molecule Type: Small molecule
Associated Items:
ID: ALA1277623
Max Phase: Preclinical
Molecular Formula: C26H32N4O6S2
Molecular Weight: 560.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@H]1CCSSC[C@@H](C(=O)NCc2ccccc2CC(=O)O)NC(=O)C[C@H](Cc2ccc(O)cc2)NC1=O
Standard InChI: InChI=1S/C26H32N4O6S2/c27-21-9-10-37-38-15-22(26(36)28-14-18-4-2-1-3-17(18)12-24(33)34)30-23(32)13-19(29-25(21)35)11-16-5-7-20(31)8-6-16/h1-8,19,21-22,31H,9-15,27H2,(H,28,36)(H,29,35)(H,30,32)(H,33,34)/t19-,21-,22-/m0/s1
Standard InChI Key: VZYRMNZEFCZSER-BVSLBCMMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 560.70 | Molecular Weight (Monoisotopic): 560.1763 | AlogP: 1.35 | #Rotatable Bonds: 7 |
Polar Surface Area: 170.85 | Molecular Species: ACID | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.18 | CX Basic pKa: 8.38 | CX LogP: -1.63 | CX LogD: -1.66 |
Aromatic Rings: 2 | Heavy Atoms: 38 | QED Weighted: 0.27 | Np Likeness Score: 0.57 |
1. Andersson H, Demaegdt H, Vauquelin G, Lindeberg G, Karlén A, Hallberg M, Erdélyi M, Hallberg A.. (2010) Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP)., 53 (22): [PMID:21047126] [10.1021/jm100793t] |
2. Mpakali A, Saridakis E, Giastas P, Maben Z, Stern LJ, Larhed M, Hallberg M, Stratikos E.. (2020) Structural Basis of Inhibition of Insulin-Regulated Aminopeptidase by a Macrocyclic Peptidic Inhibitor., 11 (7): [PMID:32676150] [10.1021/acsmedchemlett.0c00172] |
3. Barlow, Nicholas, Vanga, Sudarsana Reddy, Savmarker, Jonas, Sandstrom, Anja, Burns, Peta, Hallberg, Anders, Aqvist, Johan, Gutierrez-de-Teran, Hugo, Hallberg, Mathias, Larhed, Mats, Chai, Siew Yeen, Thompson, Philip E.. (2020) Macrocyclic peptidomimetics as inhibitors of insulin-regulated aminopeptidase (IRAP), 11 (2): [PMID:33479630] [10.1039/c9md00485h] |
Source(1):